INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-1054148730-clinical-outsourcing-partner-FSP]( "How Mobile Clinics Advance Diversity In Clinical Research")
How Mobile Clinics Advance Diversity In Clinical ResearchMobile clinics reduce participation barriers, enable more inclusive trials, deliver representative data, speed timelines, and advance equity in research.
-
![Surgeons during operation-GettyImages-909209122]( "From Months To Hours: MMC Medical's EDC Revolution")
From Months To Hours: MMC Medical's EDC RevolutionLearn how a specialized CRO reduced study build times by 95%. Discover strategies for template reusability and flexible resource scaling to accelerate early-stage medical device validation.
-
![Precision For Medicine - GettyImages-2036497889 lab]( "Receptor Occupancy In The Era Of Multispecific Therapeutics")
Receptor Occupancy In The Era Of Multispecific TherapeuticsReceptor occupancy studies face new challenges as multispecific therapeutics introduce complex target engagement, receptor trafficking, cellular interactions, and assay interpretation considerations.
-
![clinical-trials-challenges-GettyImages-1474299453]( "Beyond The Benchmark: Innovative Trial Designs Transform Research")
Beyond The Benchmark: Innovative Trial Designs Transform ResearchAdaptive designs, decentralized models, and AI insights are reshaping trials — boosting efficiency, speeding timelines, and strengthening evidence amid evolving regulations and funding pressures.
-
The Story Behind MIDBA: An Exclusive Interview8/20/2026
A new regulatory framework reduces PK bridging study needs, helping sponsors streamline device transitions, lower costs, speed up timelines, and boost regulatory predictability for combination products.
-
Decentralized Trials: The Value Of Direct-To-Patient, Pharmacy-Led Solutions5/8/2026
Pharmacy-led DTP models cut site burden, improve inventory control, and expand trial access. Learn how to optimize your decentralized trial supply chain for compliance and patient outcomes.
-
Developing And Validating Clinical Receptor Occupancy Pharmacodynamic Biomarker Assays9/25/2025
Receptor occupancy (RO) assays assess drug-target engagement and support PK/PD modeling. Accurate RO requires customized assays using stabilized blood to monitor CD6 modulation in autoimmune therapy.
-
We Can Fix What's Broken in Research—If We Solve the Right Problems4/11/2025
Addressing the root causes of inefficiencies in research is the only way to drive meaningful progress. Explore why tackling the right issues is essential to fixing broken research process.
-
Unique IRT Implementation Considerations For Personalized Medicine Trials8/22/2025
The rise of personalized and precision medicine is reshaping the clinical trial landscape and, as the number of these specialized trials increases, so does the complexity of managing them effectively.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-2081140990-phone-cellphone-hand]( "Visit Management Solution Built For Global Trials")
From reminders to resource coordination, visit scheduling shouldn't slow trials down. Discover how automation can reduce deviations and support participants.
-
![rtsm-clinical-trial-tech-GettyImages-872024272]( "PULSE: Empowering Every Phase of Your Clinical Journey")
A flexible RTSM platform improves study startup, real‑time design updates, oversight, and global supply management, enabling faster execution, clearer visibility, and streamlined trial operations.
-
![GettyImages-2176126405-digital-puzzle]( "First-In-Human To Proof-Of-Concept: The DVCR Continuity Model")
With a single, consistent team from FIH to Proof-of-Concept, this Continuity Model eliminates fragmented handoffs to keep program knowledge intact and speed your path to Phase II.
-
![GettyImages-1414481878 clinical trial, patient, diversity]( "How Trial Compass Is Solving Psychiatric Trial Enrollment")
Psychiatric trials have long been among the most difficult to enroll. From treatment-resistant depression (TRD) and PTSD to cognitive and neuro disorders, sponsors are facing the same challenges over and over again:
- Narrow I/E criteria that don’t translate into real-world patients
- Sites with limited behavioral health infrastructure
- Lack of patient trust and trial awareness in psychiatric populations
- Professional patients
- Rating scales aren’t used in clinical practices
But what if recruitment didn’t have to start with a gamble?
-
![microplate panel for diseases diagnosis GettyImages-1387090964]( "Bringing Endocrine And Metabolic Disease Treatments To Market")
Metabolic and endocrine diseases are a rising therapy area focus for clinical research due to the high demand for novel therapies that are challenged with proving safety and efficacy.
